Beijing Immunochina Medical Science & Technology Co., Ltd.
Privately held: no public share price
Assets
(3 total)
3Total Assets
0Approved
0Phase 3 / Filed
3Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | CD19Cell therapy | Systemic Lupus Erythematosus | |
IM21 CAR-T cellsNo recent activity | Phase 1 | BCMACell therapy | Multiple Myeloma |
| Phase 1 | CD19Cell therapy | Systemic Lupus Erythematosus |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.